药物对比
Acetohexamide vs Vildagliptin
比较Acetohexamide（磺脲类药物）与Vildagliptin（DPP-4抑制剂）治疗2型糖尿病：疗效、低血糖风险、对体重的影响及适用性。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when evaluating older first-generation sulfonylureas against modern DPP-4 inhibitors for type 2 diabetes patients concerned about hypoglycemia or weight gain.
结论
Vildagliptin typically offers a safer profile than Acetohexamide for most type 2 diabetes patients.
全部药物对比